Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|September 8, 2007
Pyrazole-based cathepsin S inhibitors with improved cellular potencyJianmei Wei, Barbara A Pio, Hui Cai, et al.Bioorganic & Medicinal Chemistry Letters|September 29, 2009
Pyrazole-based arylalkyne cathepsin S inhibitors. Part II: optimization of cellular potencyMichael K Ameriks, Hui Cai, James P Edwards, et al.Bioorganic & Medicinal Chemistry Letters|September 24, 2009
Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elementsMichael K Ameriks, Frank U Axe, Scott D Bembenek, et al.Bioorganic & Medicinal Chemistry Letters|March 2, 2010
Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitorsDanielle K Wiener, Alice Lee-Dutra, Scott Bembenek, et al.Molecular Pharmacology|August 30, 2012
Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking siteLi Zhang, Amy Y Shih, Xia V Yang, et al.Bioorganic & Medicinal Chemistry Letters|February 23, 2010
Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regionsJohn J M Wiener, Alvah T Wickboldt, Danielle K Wiener, et al.British Journal of Pharmacology|October 10, 2022
Identification and characterization of select oxysterols as ligands for GPR17Anthony W Harrington, Changlu Liu, Naomi Phillips, et al.The Journal of Pharmacology and Experimental Therapeutics|October 21, 2003
Identification of a potent and selective noncovalent cathepsin S inhibitorRobin L Thurmond, Siquan Sun, Clark A Sehon, et al.Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitorsDarin J Gustin, Clark A Sehon, Jianmei Wei, et al.Nature|July 29, 2011
Oxysterols direct B-cell migration through EBI2Changlu Liu, Xia V Yang, Jiejun Wu, et al.Pageof 3